ProfileGDS4718 / 236480_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 65% 41% 57% 73% 53% 41% 53% 53% 65% 57% 85% 51% 47% 42% 46% 59% 50% 53% 59% 63% 72% 56% 55% 78% 41% 64% 56% 66% 49% 43% 36% 65% 46% 53% 39% 49% 60% 54% 41% 60% 46% 35% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1288160
GSM549102patient 115, normal, homogenized [OPG study]6.5074965
GSM549104patient 119, normal, homogenized [OPG study]5.0374641
GSM549108patient 138, normal, homogenized [OPG study]5.986257
GSM549119patient 077, normal, homogenized [OPG study]7.0624973
GSM549133patient 032, cancer, homogenized [OPG study]5.6360753
GSM549139patient 042, cancer, homogenized [OPG study]5.0039241
GSM549099patient 107, normal, homogenized [OPG study]5.6597553
GSM549109patient 139, normal, homogenized [OPG study]5.7209853
GSM549110patient 046, normal, homogenized [OPG study]6.4718465
GSM549114patient 063, normal, homogenized [OPG study]5.8923757
GSM549122patient 082, normal, homogenized [OPG study]8.5315985
GSM549134patient 033, cancer, homogenized [OPG study]5.5394751
GSM549136patient 036, cancer, homogenized [OPG study]5.2775447
GSM549140patient 044, cancer, homogenized [OPG study]5.0768942
GSM549111patient 047, normal, homogenized [OPG study]5.2552846
GSM549113patient 057, normal, homogenized [OPG study]5.9954159
GSM549132patient 031, cancer, homogenized [OPG study]5.4836550
GSM549137patient 038, cancer, homogenized [OPG study]5.6613353
GSM549142patient 047, cancer, homogenized [OPG study]6.1351859
GSM549100patient 110, normal, homogenized [OPG study]6.277163
GSM549107patient 135, normal, homogenized [OPG study]7.0084772
GSM549115patient 068, normal, homogenized [OPG study]5.8027356
GSM549116patient 072, normal, homogenized [OPG study]5.7886155
GSM549120patient 078, normal, homogenized [OPG study]7.5827878
GSM549131patient 030, cancer, homogenized [OPG study]5.0016741
GSM549118patient 074, normal, homogenized [OPG study]6.4423464
GSM549129patient 027, cancer, homogenized [OPG study]5.9063956
GSM549123patient 088, normal, homogenized [OPG study]6.590166
GSM549124patient 006, cancer, homogenized [OPG study]5.4896349
GSM549126patient 015, cancer, homogenized [OPG study]5.1305343
GSM549128patient 025, cancer, homogenized [OPG study]4.7903636
GSM549103patient 117, normal, homogenized [OPG study]6.4586965
GSM549117patient 073, normal, homogenized [OPG study]5.2620846
GSM549138patient 041, cancer, homogenized [OPG study]5.7050553
GSM549141patient 045, cancer, homogenized [OPG study]4.8632239
GSM549130patient 028, cancer, homogenized [OPG study]5.4795249
GSM549101patient 111, normal, homogenized [OPG study]6.1720160
GSM549105patient 128, normal, homogenized [OPG study]5.7456154
GSM549106patient 134, normal, homogenized [OPG study]4.9889241
GSM549112patient 048, normal, homogenized [OPG study]6.1068260
GSM549125patient 011, cancer, homogenized [OPG study]5.3292546
GSM549127patient 024, cancer, homogenized [OPG study]4.7677635
GSM549135patient 035, cancer, homogenized [OPG study]5.6194952